All News

The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson

March 30, 2020 / Thomas Brewster, Forbes Staff The Trump administration is spending nearly half a billion dollars on one company in the race to find a coronavirus vaccine. That’s according to a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen, which specified a “new vaccine asset for 2019 Novel Coronavirus (COVID-19),” Forbes found. It’s …

‘Life may change for us all’: How we respond to the coronavirus crisis will be defining, historians say

March 29, 2020 / Marco della Cava, USA TODAY When historians mark the start of this nation’s coronavirus nightmare, they will cite Jan. 21, 2020, the date a Washington state man in his 30s who had visited Wuhan, China, was confirmed as the United States’ first COVID-19 case. Since then, this global crisis has mushroomed into a national defining moment with as yet …

Federal agencies warned of ventilator shortages for nearly two decades

March 30, 2020 / By Ronn Blitzer | Fox News The overwhelming number of coronavirus patients flooding hospitals across the U.S. has resulted in a shortage of ventilators for those experiencing difficulty breathing. But while President Trump has faced criticism from states, like New York, for the short supply, federal agencies have been predicting the need for more ventilators for nearly two …

Coronavirus patients in Houston hospital becoming first in US to try experimental plasma transfusion

March 30, 2020 / By Chris Ciaccia | Fox News A Houston-area hospital became the first hospital in the U.S. to transfuse blood plasma of a recovered COVID-19 patient into one that is critically ill, an experimental therapy that could be used in the fight against the novel coronavirus. The Houston Chronicle reported that Houston Methodist Hospital transfused the plasma on …

Experimental coronavirus treatment using antiviral remdesivir expanded by developer Gilead

March 30, 2020 / By James Rogers | Fox News Biotech company Gilead Sciences is expanding access to its antiviral drug remdesivir as an experimental coronavirus treatment. In an open letter sent out Saturday, Gilead CEO Daniel O’Day said the company is carefully ramping up its efforts to make remdesivir available to coronavirus patients. The antiviral has previously been used to treat …

Trump administration in talks with India to avoid U.S. drug supply shortage

March 30, 2020 / By Dan De Luce, Abigail Williams and Carol E. Lee WASHINGTON — Trump administration officials are asking India to lift restrictions to give the U.S. access to pharmaceutical ingredients needed to produce a range of drugs, amid fears of a potential U.S. drug supply shortage prompted by the coronavirus outbreak, three sources familiar with …

New York’s Central Park and harbor are now home to makeshift hospitals

March 30, 2020 / By Madeline Holcombe, Holly Yan and Eric Levenson, CNN (CNN) – New York transformed a grassy meadow in Central Park into a makeshift hospital and welcomed a Navy hospital ship as officials scrambled to bolster a medical system becoming overwhelmed by coronavirus. Central Park’s East Meadow on the Upper East Side, normally a spot for …

HHS wants daily COVID-19 results from hospital with in-house labs

March 29, 2020 / Modern Healthcare The Trump administration on Sunday sent a letter to hospitals Sunday “requesting” that they report their COVID-19 testing data to HHS on a daily basis. “We understand you may be reporting to your state, but the data is needed at the federal level to support FEMA and the Centers for Disease …

$2 trillion wasn’t enough: Lawmakers already eyeing another coronavirus response bill

March 30, 2020 / By Brooke Singman | Fox News On the heels of the largest stimulus package passed in U.S. history, lawmakers on Capitol Hill and administration officials are contemplating yet another piece of legislation to provide economic relief amid the coronavirus outbreak. The latest indication came Monday, when Treasury Secretary Steven Mnuchin said he would be willing …

Stimulus package sets up clash over payment for COVID-19 tests

March 29, 2020 / RACHEL COHRS  Congress has spent months in stalemate over how best to protect patients from surprise out-of-network medical bills, and lawmakers’ efforts to keep COVID-19 tests affordable for patients could prove an informative test case. Insurers claim that new laws passed in response to COVID-19 could allow out-of-network labs to name …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1